Skip to Main Content

Author Details

Jarad Schiffer
Centers for Disease Control and Prevention
1993
44
17
PMIDPaper TitleJournal TitlePublished Year
37787062Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015-2016.Clin Infect Dis2024
35642525Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series.Clin Infect Dis2023
35271558Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.MMWR Morb Mortal Wkly Rep2022
35856710SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection.Microbiol Spectr2022
33300579Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey.Clin Infect Dis2021
33817624Effect of maternal Tdap on infant antibody response to a primary vaccination series with whole cell pertussis vaccine in São Paulo, Brazil.Vaccine X2021
33639620Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.Clin Infect Dis2021
34698287Pregnancy, Birth, Infant, and Early Childhood Neurodevelopmental Outcomes among a Cohort of Women with Symptoms of Zika Virus Disease during Pregnancy in Three Surveillance Sites, Project <i>Vigilancia de Embarazadas con Zika</i> (VEZ), Colombia, 2016-2018.Trop Med Infect Dis2021
34013349Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein.J Infect Dis2021
33252659Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020.Clin Infect Dis2021
32881855Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.MMWR Morb Mortal Wkly Rep2020
31941807Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice.mSphere2020
33237893Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.MMWR Morb Mortal Wkly Rep2020
32692365Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.JAMA Intern Med2020
32709433Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy.Vaccine2020
30671034<i>Streptococcus infantis, Streptococcus mitis</i>, and <i>Streptococcus oralis</i> Strains With Highly Similar <i>cps5</i> Loci and Antigenic Relatedness to Serotype 5 Pneumococci.Front Microbiol2019
31834290Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019.MMWR Recomm Rep2019
31682557Partnerships Involved in Public Health Testing for Zika Virus in Florida, 2016.Public Health Rep2019
31181219Performance of InBios ZIKV Detectâ¿¢ 2.0 IgM Capture ELISA in two reference laboratories compared to the original ZIKV Detectâ¿¢ IgM Capture ELISA.J Virol Methods2019
30458978Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.Biologicals2019
30297122Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting.Vaccine2018
29964076Multi-laboratory comparison of three commercially available Zika IgM enzyme-linked immunosorbent assays.J Virol Methods2018
27814939Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.Biologicals2017
26865594Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.Clin Vaccine Immunol2016
27558619Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.Vaccine2016
27155494Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.Vaccine2016
26942655Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.Expert Rev Vaccines2016
26072016Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.Vaccine2015
24373307Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.Vaccine2014
25185577Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.Clin Vaccine Immunol2014
24857756Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.J Immunol Methods2014
23266055Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.Biologicals2013
22197974Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.J Immunol Methods2012
22972844Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge.Sci Transl Med2012
22933399A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.Clin Vaccine Immunol2012
22528152Influenza virus titration, antigenic characterization, and serological methods for antibody detection.Methods Mol Biol2012
21471339Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.J Clin Microbiol2011
21857352Standardization and monitoring of laboratory performance and quality assurance by use of the less-sensitive HIV incidence assay: seven years of results.J Acquir Immune Defic Syndr2011
21908727Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.J Infect Dis2011
20619255Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.Clin Chim Acta2010
20875951A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.Biologicals2010
19199567Analysis of perchlorate in dried blood spots using ion chromatography and tandem mass spectrometry.Anal Chem2009
7529729The M2 transmembrane segment as a molecular determinant of the ion permeation properties in the superfamily of ligand-gated ion channels.Biochem Soc Trans1994
8259512Protein design by binary patterning of polar and nonpolar amino acids.Science1993
  • 1 - 44 of 44

Recommended Authors

Yale School of Public Health
Career Start Year 2019
Number of shared co-authors 1
University of California San Francisco School of Medicine
Career Start Year 2018
Number of shared co-authors 1
College of Public Health and Health Professions, University of Florida
Career Start Year 2017
Number of shared co-authors 1
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Chulalongkorn University
Career Start Year 2015
Number of shared co-authors 0
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 0
University of Bordeaux, Inserm, EUCLID/F-CRIN Clinical Trials Platform
Career Start Year 2013
Number of shared co-authors 1
Division of Clinical Microbiology, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 1
Yale School of Public Health
Career Start Year 2010
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 2009
Number of shared co-authors 1
ZIP Diagnostics Pty Ltd.
Career Start Year 2006
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 4
University of Florida
Career Start Year 2004
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 10
Vitalant Research Institute
Career Start Year 2003
Number of shared co-authors 4
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 0
University of Maryland
Career Start Year 2000
Number of shared co-authors 0
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 1
Centers for Disease Control and Prevention
Career Start Year 1998
Number of shared co-authors 23
Kaiser Permanente Washington Health Research Institute
Career Start Year 1998
Number of shared co-authors 0
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 1
Oak Crest Institute of Science
Career Start Year 1992
Number of shared co-authors 1
Saint Louis University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
University of Washington, Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 21
Massachusetts General Hospital
Career Start Year 1988
Number of shared co-authors 1
Marshfield Clinic Research Institute
Career Start Year 1987
Number of shared co-authors 9
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 7
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 0
University of California berkeley
Career Start Year 1971
Number of shared co-authors 3

Collaborators

Centers for Disease Control and Prevention
Co-authored papers 15
US Centers for Disease Control and Prevention COVID-19 Response Team
Co-authored papers 12
Centers for Disease Control and Prevention (CDC)
Co-authored papers 7
Battelle Memorial Institute
Co-authored papers 4
Centers for Disease Control and Prevention
Co-authored papers 2
Beth Israel Deaconess Medical Center
Co-authored papers 2
Wake Forest University
Co-authored papers 2
Albert Einstein College of Medicine
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
Co-authored papers 2
University of California los angeles
Co-authored papers 2
US Centers for Disease Control and Prevention
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Mayo Clinic Vaccine Research Group
Co-authored papers 2
Intermountain Medical Center and the University of Utah
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Intermountain Medical Center and University of Utah
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
Montefiore Medical Center, Albert Einstein College of Medicine
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
University of Massachusetts Medical School - Baystate
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
University of Washington
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Duke University
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Hennepin County Medical Center
Co-authored papers 2
Johns Hopkins University
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2